| |
 |
|
Class Information
Number: 514/43
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > N-glycoside > Nitrogen containing hetero ring
Description: Subject matter wherein the aglycone portion contains a nitrogen containing hetero ring.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/52 |
Phosphorus containing (e.g., vitamin b12, etc.) |
258 |
| 514/44 |
Polynucleotide (e.g., rna, dna, etc.) |
3,242 |
| 514/45 |
Purines (including hydrogenated) (e.g., adenine, guanine, etc.) |
537 |
| 514/49 |
Pyrimidines (including hydrogenated) (e.g., cytosine, etc.) |
503 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5863903 |
Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes |
Jan. 26, 1999 |
| 5843937 |
DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
Dec. 1, 1998 |
| 5843912 |
Ring-expanded nucleosides and nucleotides |
Dec. 1, 1998 |
| 5840705 |
.alpha.-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed |
Nov. 24, 1998 |
| 5827831 |
Lipid nucleotide analog prodrugs for oral administration |
Oct. 27, 1998 |
| 5804564 |
Antitumor indolopyrrolocarbazole derivatives |
Sep. 8, 1998 |
| 5789387 |
Methods and compositions for treating fungal infections in mammals |
Aug. 4, 1998 |
| 5776925 |
Methods for cancer chemosensitization |
Jul. 7, 1998 |
| 5767098 |
Anti-acne method and composition |
Jun. 16, 1998 |
| 5767097 |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
Jun. 16, 1998 |
| 5763242 |
Method for increasing transduction efficiency of recombinant retroviral vectors |
Jun. 9, 1998 |
| 5753221 |
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions |
May. 19, 1998 |
| 5753613 |
Compositions for the introduction of polyanionic materials into cells |
May. 19, 1998 |
| 5747496 |
Inhibitors of platelet aggregation |
May. 5, 1998 |
| 5736554 |
Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
Apr. 7, 1998 |
| 5712256 |
Ribonucleotide preparations and uses thereof |
Jan. 27, 1998 |
| 5712255 |
Treatment of herpes infections with polysubstituted benzimidazoles |
Jan. 27, 1998 |
| 5707971 |
Modulation of glycolytic ATP production |
Jan. 13, 1998 |
| 5705490 |
Polysubstituted benzimidazoles as antiviral agents |
Jan. 6, 1998 |
| 5679646 |
Solvent for a sparingly soluble gentamicin salt |
Oct. 21, 1997 |
| 5665709 |
Polysubstituted benzimidazole nucleosides as antiviral agents |
Sep. 9, 1997 |
| 5661134 |
Oligonucleotides for modulating Ha-ras or Ki-ras having phosphorothioate linkages of high chiral purity |
Aug. 26, 1997 |
| 5658880 |
Sialic acid/fucose based medicaments |
Aug. 19, 1997 |
| 5658890 |
C-nucleoside isostere of nicotinamide adenine dinucleotide, analogs thereof and use as anti-cancer agent |
Aug. 19, 1997 |
| 5658889 |
Method and compounds for aica riboside delivery and for lowering blood glucose |
Aug. 19, 1997 |
| 5654283 |
Polysubstituted benzimidazoles as antiviral agents |
Aug. 5, 1997 |
| 5654287 |
Method of treating cancer by conjunctive therapy with N,N.sup.1 -bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent |
Aug. 5, 1997 |
| 5650412 |
HIV protease inhibitors useful for the treatment of AIDS |
Jul. 22, 1997 |
| 5646125 |
Polysubstituted benzimidazoles as antiviral agents |
Jul. 8, 1997 |
| 5646152 |
Methods of administering CRF antagonists |
Jul. 8, 1997 |
| 5643888 |
Regulating retroviral replication, infection, and pathogenesis |
Jul. 1, 1997 |
| 5635488 |
Compounds having phosphorodithioate linkages of high chiral purity |
Jun. 3, 1997 |
| 5633261 |
Immunostimulating swainsonine analogs |
May. 27, 1997 |
| 5618793 |
Nikkomycin analogs |
Apr. 8, 1997 |
| 5607922 |
1,5-anhydrohexitol nucleoside analogues |
Mar. 4, 1997 |
| 5607685 |
Protracted-release adminstration forms containing clindamycin palmitate |
Mar. 4, 1997 |
| 5599797 |
Oligonucleotides having phosphorothioate linkages of high chiral purity |
Feb. 4, 1997 |
| 5591758 |
Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
Jan. 7, 1997 |
| 5587371 |
Texaphyrin-oligonucleotide conjugates |
Dec. 24, 1996 |
| 5580547 |
Stimulation of tanning by DNA fragments or single-stranded DNA |
Dec. 3, 1996 |
| 5576302 |
Oligonucleotides for modulating hepatitis C virus having phosphorothioate linkages of high chiral purity |
Nov. 19, 1996 |
| 5569650 |
C-nucleoside isosters of analogs thereof and pharmaceutical compositions |
Oct. 29, 1996 |
| 5567686 |
Method for protection against genotoxic mutagenesis |
Oct. 22, 1996 |
| 5552311 |
Purine nucleoside phosphorylase gene therapy for human malignancy |
Sep. 3, 1996 |
| 5545636 |
Protein kinase C inhibitors |
Aug. 13, 1996 |
| 5540931 |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
Jul. 30, 1996 |
| 5506212 |
Oligonucleotides with substantially chirally pure phosphorothioate linkages |
Apr. 9, 1996 |
| 5504078 |
.alpha.-glucosidase inhibitors |
Apr. 2, 1996 |
| 5496809 |
Stable solutions of rebeccamycin analog |
Mar. 5, 1996 |
| 5488042 |
Method for protection against genotoxic mutagenesis |
Jan. 30, 1996 |
|
|
|
